Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Treasury Shares (2019 - 2025)

Historic Treasury Shares for Keros Therapeutics (KROS) over the last 3 years, with Q3 2025 value amounting to $721700.0.

  • Keros Therapeutics' Treasury Shares changed N/A to $721700.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $721700.0, marking a year-over-year change of. This contributed to the annual value of $34557.0 for FY2019, which is N/A changed from last year.
  • As of Q3 2025, Keros Therapeutics' Treasury Shares stood at $721700.0.
  • Keros Therapeutics' Treasury Shares' 5-year high stood at $882775.0 during Q1 2025, with a 5-year trough of $721700.0 in Q3 2025.